Information & registration worldwide Members’ Conference 2022
After our last ‘real’ global Members Conference in 2019, it has not been possible for a number of years due to COVID-19 to organize a conference where you can see each other in person. In 2022 this will be possible again and that is also our 25th anniversary year!
Family Day 2 July 2022: de Efteling
Finally we can organize our International Family Day again! On Saturday 2 July we are going to the Efteling! There is something for all ages to experience from Fairytale Forest to all kinds of roller coasters. More information and registration
VASCA Workgroup Conference spring 2022 – Brussels
On the 6th of April 2022, the annual Spring Meeting of the VASCA work group (a division of ERN VASCERN) was organised in Brussels. VASCERN is one of the European Reference Networks (ERNs) in the field of rare multisystemic vascular diseases. We as an organisation are affiliated with the ERNs VASCERN and SKIN. All care […]
Launch Global Dermatology Coalition
On May 25th 2022 a patient-led multi-stakeholder group of like-minded organizations – including dermatology patient organizations, health care professionals (dermatologists and dermatology nurses), researchers, and industry – announced the formation of the Global Dermatology Coalition. This announcement comes during the 75th World Health Assembly in Geneva, as a first step in changing perceptions about the […]
08. Parents Support Guide
A series of practical booklets for parents during the different phases of their child’s life Parents Support Guide in multiple languages
Webinar 12 February 2022 – Overgrowth and vascular malformations
Prof Chantal van der Horst was a plastic surgeon at the AMC Amsterdam until her retirement in mid-2019. She focused mainly on congenital vascular abnormalities. In this webinar, Van der Horst discusses overgrowth and in particular segmental overgrowth. This is excessive overgrowth that occurs in certain parts of the body, for example one big finger, […]
03. DCMO folder
A practical folder about DCMO. The DCMO folder in multiple languages
Approval alpelisib by FDA
Novartis’ medicine Vijoice® (alpelisib) has recently (6 April) been approved by the US Food and Drug Administration (FDA) for the treatment of patients aged two years and older with severe manifestations of PIK3CA-related overgrowth syndrome (PROS). Until today, the only treatment options for these patients are surgical or interventional radiology procedures. More information
Translation team Zuyd University of Applied Sciences 2022
Our organization operates worldwide, which means that we offer our information in multiple languages. For example, our website is available in English and Dutch and our information leaflets in at least German, English, French, Dutch and Spanish. The translation work takes quite some time and we are always looking for volunteers to help. Zuyd Vertalingen […]
01. AVM folder
A practical folder about AVM. The AVM folder in multiple languages